13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 28 holding rows worth $483,855,000.
- Accession
- 0001172661-21-001313
- Filer
- CIK 1281446
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 28 entries on the cover page, a total value of $483,855,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $483,855,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MACROGENICS INC | 556099109 | COM | 1,350,000 | $42,998,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 760,000 | $33,721,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 930,000 | $29,444,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 382,085 | $28,599,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 1,332,773 | $27,828,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,201,100 | $27,133,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 156,406 | $26,162,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 375,870 | $26,082,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 89,600 | $23,378,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 135,000 | $23,126,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 75,000 | $20,981,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 861,410 | $20,415,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 872,415 | $20,406,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 4,755,000 | $18,497,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,007,012 | $16,525,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 593,712 | $14,825,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 649,516 | $13,880,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,300,000 | $12,636,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 80,000 | $11,160,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 2,200,000 | $8,580,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 311,217 | $8,029,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 114,345 | $5,230,000 | thousands by filing date | |
| REDHILL BIOPHARMA LTD | 757468103 | ADR | 705,305 | $5,163,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 250,000 | $4,565,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 150,000 | $4,536,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 2,610,000 | $4,124,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 502,900 | $3,983,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 349,600 | $1,849,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-21-001313 | this filing | 2021-05-17 | acceptance time not in the bulk data set |